Advertisement
UK markets close in 4 hours 6 minutes
  • FTSE 100

    8,227.24
    +47.56 (+0.58%)
     
  • FTSE 250

    20,385.26
    +53.46 (+0.26%)
     
  • AIM

    765.91
    +1.44 (+0.19%)
     
  • GBP/EUR

    1.1816
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2651
    +0.0009 (+0.07%)
     
  • Bitcoin GBP

    48,708.29
    +420.48 (+0.87%)
     
  • CMC Crypto 200

    1,280.79
    -3.04 (-0.24%)
     
  • S&P 500

    5,482.87
    +4.97 (+0.09%)
     
  • DOW

    39,164.06
    +36.26 (+0.09%)
     
  • CRUDE OIL

    82.44
    +0.70 (+0.86%)
     
  • GOLD FUTURES

    2,345.40
    +8.80 (+0.38%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.14 (+0.01%)
     
  • DAX

    18,319.64
    +109.09 (+0.60%)
     
  • CAC 40

    7,506.87
    -23.85 (-0.32%)
     

Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug

Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug

Alnylam stock catapulted Monday after its experimental heart-disease treatment topped expectations in a highly anticipated study.